Management of previously untreated patients with severe haemophilia A preferentially treated with recombinant factor VIII products: Two French centres' real-life experience.
Nicolas DrillaudAntoine BabutyLucia RugeriMarc FouassierAnne LienhartMarie-C BénéCarole LefrancCatherine TernisienValérie ChamouardMarianne SigaudMartine PennetierMarc TrossaërtSandrine MeunierPublished in: Haemophilia : the official journal of the World Federation of Hemophilia (2020)